TrianecT

Utrecht, The Netherlands

TrianecT develops and commercializes StrokePointer to diagnose stroke in the ambulance

$1.6M raised

Jul 2025

Seed

Top Investors

XO VenturesCbusineZ

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has TrianecT raised?

TrianecT has raised $1.6M in total funding. The most recent round was Seed. The last funding was announced in July 2025.

Who are TrianecT's investors?

TrianecT's investors include XO Ventures, CbusineZ.

Where is TrianecT headquartered?

TrianecT is headquartered in Utrecht, The Netherlands.

What does TrianecT do?

TrianecT develops and commercializes StrokePointer to diagnose stroke in the ambulance

What stage is TrianecT at?

TrianecT is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated July 8, 2025.

MLA

"TrianecT — Funding & Investors." VCBacked, July 8, 2025, https://www.vcbacked.co/company/trianect. Accessed June 3, 2026.

APA

VCBacked. (2025). TrianecT — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/trianect

Wikipedia (cite web)

{{cite web |title=TrianecT — Funding & Investors |url=https://www.vcbacked.co/company/trianect |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated July 8, 2025.